{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:11:17Z","timestamp":1780459877975,"version":"3.54.1"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Chronic kidney disease (CKD) is a major global public health issue. Both hyperhomocysteinemia (HHcy) and hyperuricemia are independent risk factors for CKD. In this study, we evaluated the association of HHcy and hyperuricemia with CKD in the middle-aged and elderly populations in Taiwan.<\/jats:p>\n            <jats:p>In this cross-sectional study, we collected the data of 5910 patients aged \u226550\u200ayears after their self-paid health examination at a single medical center. Homocysteine (Hcy) levels were divided into 4 quartiles (Q1, &lt;8.2; Q2, 8.2\u20139.8; Q3, 9.9\u201311.7; and Q4, &gt;11.7\u200a\u03bcM\/L). Renal function was determined using the Chronic Kidney Disease Epidemiology Collaboration equation. Patients were considered to have CKD if their estimated glomerular filtration rate was\u200a&lt;\u200a60\u200amL\/min\/1.73\u200am<jats:sup>2<\/jats:sup>.<\/jats:p>\n            <jats:p>The prevalence of CKD significantly increased with the quartiles of uric acid (UA) and Hcy. In multiple logistic regression analysis, the odds ratios (ORs) of CKD increased with the quartiles of Hcy, independent of UA. There was 22.9 in Q4 in the normal serum UA group and 18.3 in the hyperuricemia group compared with Q1 of Hcy. Both hyperuricemia (OR 2.9) and Q4 of Hcy (OR 8.1) were significant independent risk factors for CKD. Furthermore, hyperuricemia and HHcy had significant synergistic association (synergy index, 1.7) with CKD.<\/jats:p>\n            <jats:p>The ORs of CKD increased with the quartiles of Hcy, independent of hyperuricemia. Hyperuricemia and HHcy had synergistic association with CKD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027202","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T13:13:12Z","timestamp":1631884392000},"page":"e27202","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Synergistic association of hyperuricemia and hyperhomocysteinemia with chronic kidney disease in middle-aged adults and the elderly population"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8471-2109","authenticated-orcid":false,"given":"Peng-Tzu","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Dar","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan"},{"name":"School of Medicine, Fu Jen Catholic University, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(08)60952-6","article-title":"All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan","volume":"371","author":"Wen","year":"2008","journal-title":"Lancet"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971\u20131992. National Health and Nutrition Examination Survey","volume":"283","author":"Fang","year":"2000","journal-title":"Jama"},{"issue":"(Suppl 2)","key":"R3-20250504","doi-asserted-by":"crossref","first-page":"03","DOI":"10.1111\/j.1440-1797.2010.01304.x","article-title":"Epidemiology, impact and preventive care of chronic kidney disease in Taiwan","volume":"15","author":"Hwang","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/ndt\/gfn609","article-title":"Comparison of the prevalence of chronic kidney disease among different ethnicities: Beijing CKD survey and American NHANES","volume":"24","author":"Xu","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000114300","article-title":"Positive association between plasma homocysteine level and chronic kidney disease","volume":"31","author":"Shankar","year":"2008","journal-title":"Kidney Blood Press Res"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0272-6386(04)00813-3","article-title":"Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study","volume":"44","author":"Ninomiya","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3346\/jkms.2014.29.6.788","article-title":"Elevated serum homocysteine levels were not correlated with serum uric acid levels, but with decreased renal function in gouty patients","volume":"29","author":"Choi","year":"2014","journal-title":"J Korean Med Sci"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-140-2-200401200-00009","article-title":"Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus","volume":"140","author":"Soinio","year":"2004","journal-title":"Ann Intern Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40620-013-0037-9","article-title":"Serum homocysteine level is positively associated with chronic kidney disease in a Taiwan Chinese population","volume":"27","author":"Chao","year":"2014","journal-title":"J Nephrol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"16268","DOI":"10.1038\/srep16268","article-title":"Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults","volume":"5","author":"Xie","year":"2015","journal-title":"Sci Rep"},{"issue":"(12 Suppl 3)","key":"R13-20250504","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1681\/ASN.2006080909","article-title":"Uric acid, the metabolic syndrome, and renal disease","volume":"17","author":"Cirillo","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.ki.5000391","article-title":"Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease","volume":"69","author":"Nakagawa","year":"2006","journal-title":"Kidney Int"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.HYP.0000150785.39055.e8","article-title":"Resurrection of uric acid as a causal risk factor in essential hypertension","volume":"45","author":"Johnson","year":"2005","journal-title":"Hypertension"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1681\/ASN.2005010063","article-title":"Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?","volume":"16","author":"Johnson","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jare.2016.11.004","article-title":"Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review","volume":"8","author":"Sharaf El Din","year":"2017","journal-title":"J Adv Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","article-title":"A role for uric acid in the progression of renal disease","volume":"13","author":"Kang","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1681\/ASN.2005050572","article-title":"Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells","volume":"16","author":"Kang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"Khosla","year":"2005","journal-title":"Kidney Int"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000326848","article-title":"Uric acid levels predict future development of chronic kidney disease","volume":"33","author":"Sonoda","year":"2011","journal-title":"Am J Nephrol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00074.x","article-title":"Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats","volume":"67","author":"S\u00e1nchez-Lozada","year":"2005","journal-title":"Kidney Int"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e0137449","DOI":"10.1371\/journal.pone.0137449","article-title":"Relationship between serum uric acid levels and chronic kidney disease in a Japanese cohort with normal or mildly reduced kidney function","volume":"10","author":"Toyama","year":"2015","journal-title":"PLoS One"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10157-012-0743-y","article-title":"The association between serum uric acid and renal damage in a community-based population: the Takahata study","volume":"17","author":"Suzuki","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11255-016-1452-3","article-title":"Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort","volume":"49","author":"Kong","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"e100801","DOI":"10.1371\/journal.pone.0100801","article-title":"Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"F1134","DOI":"10.1152\/ajprenal.00104.2008","article-title":"Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia","volume":"295","author":"S\u00e1nchez-Lozada","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000368507","article-title":"Relationship between serum uric acid levels and intrarenal hemodynamic parameters","volume":"40","author":"Uedono","year":"2015","journal-title":"Kidney Blood Press Res"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"F1105","DOI":"10.1152\/ajprenal.00170.2002","article-title":"Mild hyperuricemia induces glomerular hypertension in normal rats","volume":"283","author":"S\u00e1nchez-Lozada","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","article-title":"Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system","volume":"26","author":"Corry","year":"2008","journal-title":"J Hypertens"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"F471","DOI":"10.1152\/ajprenal.00560.2012","article-title":"Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease","volume":"304","author":"Ryu","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","article-title":"Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism","volume":"282","author":"Mazzali","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.ki.5002031","article-title":"Homocysteine induces mesangial cell apoptosis via activation of p38-mitogen-activated protein kinase","volume":"71","author":"Shastry","year":"2007","journal-title":"Kidney Int"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1523-1755.2004.00510.x","article-title":"Hyperhomocysteinemia activates NF-kappaB and inducible nitric oxide synthase in the kidney","volume":"65","author":"Zhang","year":"2004","journal-title":"Kidney Int"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/hy02t2.102992","article-title":"Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension","volume":"39","author":"Li","year":"2002","journal-title":"Hypertension"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/01.CIR.0000027586.64231.1B","article-title":"Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function","volume":"106","author":"Chen","year":"2002","journal-title":"Circulation"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"H2649","DOI":"10.1152\/ajpheart.00548.2005","article-title":"Mechanisms of homocysteine-induced oxidative stress","volume":"289","author":"Tyagi","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1089\/ars.2010.3721","article-title":"Mechanisms of cardiovascular remodeling in hyperhomocysteinemia","volume":"15","author":"Steed","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1074\/jbc.272.27.17012","article-title":"Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase","volume":"272","author":"Upchurch","year":"1997","journal-title":"J Biol Chem"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000101471","article-title":"Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats","volume":"27","author":"Yi","year":"2007","journal-title":"Am J Nephrol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.ki.5001517","article-title":"Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats","volume":"70","author":"Yi","year":"2006","journal-title":"Kidney Int"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1523-1755.2002.kid558.x","article-title":"Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia","volume":"62","author":"Kumagai","year":"2002","journal-title":"Kidney Int"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1172\/JCI23577","article-title":"What determines glomerular capillary permeability?","volume":"114","author":"Deen","year":"2004","journal-title":"J Clin Invest"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"03","DOI":"10.1016\/j.semnephrol.2005.06.002","article-title":"Causes of hyperhomocysteinemia in patients with chronic kidney diseases","volume":"26","author":"Garibotto","year":"2006","journal-title":"Semin Nephrol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1681\/ASN.V12102181","article-title":"The kidney and homocysteine metabolism","volume":"12","author":"Friedman","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1046\/j.1523-1755.1999.00378.x","article-title":"Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis","volume":"55","author":"Moustapha","year":"1999","journal-title":"Kidney Int"},{"issue":"(Suppl 1)","key":"R48-20250504","doi-asserted-by":"crossref","first-page":"04","DOI":"10.1111\/j.1755-6686.2010.00171.x","article-title":"Clinical epidemiology of cardiovascular disease in chronic kidney disease","volume":"36","author":"Foley","year":"2010","journal-title":"J Ren Care"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/00365519609088586","article-title":"The effect of reduced glomerular filtration rate on plasma total homocysteine concentration","volume":"56","author":"Arnadottir","year":"1996","journal-title":"Scand J Clin Lab Invest"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0021-9150(01)00502-0","article-title":"Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate","volume":"159","author":"Bostom","year":"2001","journal-title":"Atherosclerosis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:33:00Z","timestamp":1746340380000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":50,"journal-issue":{"issue":"37","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027202","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"2021-04-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}